EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus

Negar Shavandi, Paula D Robinson, Shana Jacobs, L Lee Dupuis iD, International Pediatric Dexamethasone Panel

Pediatric Blood & Cancer · 2026-07 · 73 (7)

DOI: 10.1002/1545-5017.70299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 09.04.2026. Verfasst von Negar Shavandi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: Dexamethasone, Vomiting, Nausea, Antiemetics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An international Delphi panel of experts developed consensus statements to delineate the circumstances where the risks of dexamethasone as an antiemetic do and do not outweigh its benefits. Procedure Experts in supportive care of pediatric patients were invited to participate. Using Delphi methods, the study was conducted as four electronic surveys and three virtual meetings. In Survey 1, panelists provided demographic information and described institutional practices regarding dexamethasone use in chemotherapy‐naïve pediatric patients receiving moderately emetogenic chemotherapy (MEC) or highly emetogenic chemotherapy (HEC). In Surveys 2–4, panelists indicated their beliefs regarding the risks versus benefits of dexamethasone as an antiemetic in chemotherapy‐therapy‐naïve patients about to receive MEC or HEC in various scenarios. Evidence regarding the risks of dexamethasone was discussed at each virtual meeting, together with the survey results. Consensus was defined as occurring when at least 75% of panelists responded, and 80% of respondents agreed.

Results

Sixteen panelists participated. Consensus was achieved that the benefits of dexamethasone as an antiemetic outweigh its risks in pediatric patients with bone tumors, germ cell tumors (other than central nervous system), hepatoblastoma, retinoblastoma, or rhabdomyosarcoma or in pediatric patients undergoing autologous hematopoietic stem cell transplant. Consensus was also achieved that the benefits of dexamethasone as an antiemetic do not outweigh its risks in pediatric patients undergoing chimeric receptor antigen T‐cell therapy or with known fungal infection.

Conclusions

The consensus statements of the Delphi panel provide guidance on dexamethasone use as an antiemetic in chemotherapy‐naïve pediatric patients receiving MEC or HEC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneVomitingNauseaAntiemeticsAntineoplastic AgentsNeoplasmsHumansChildFemaleDelphi TechniqueChild, Preschool

Stichwörter der Autor:innen

antiemetic agentschemotherapy‐induced vomitingdexamethasone

Substanzen

DexamethasoneAntiemeticsAntineoplastic Agents

Autor:innen und Institutionen

  • Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
  • Pediatric Oncology Group of Ontario, Toronto, Canada.
  • GW Cancer Center, Children's National Medical Center and George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
  • Research Institute and Department of Pharmacy, The Hospital for Sick Children, Toronto, Canada.

ORCID-Profile: L Lee Dupuis

Zitieren

APA

Shavandi, N., Robinson, P. D., Jacobs, S., Dupuis, L. L., & International Pediatric Dexamethasone Panel (2026). Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus. Pediatric Blood & Cancer, 73(7). https://doi.org/10.1002/1545-5017.70299

Vancouver

Shavandi N, Robinson PD, Jacobs S, Dupuis LL, International Pediatric Dexamethasone Panel. Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus. Pediatric Blood & Cancer. 2026;73(7). doi:10.1002/1545-5017.70299

BibTeX
@article{Shavandi2026,
  author = {Shavandi, Negar and Robinson, Paula D and Jacobs, Shana and Dupuis, L Lee and International Pediatric Dexamethasone Panel, International Pediatric Dexamethasone Panel},
  title = {Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {7},
  doi = {10.1002/1545-5017.70299}
}
Kostenlos starten →